Your browser doesn't support javascript.
loading
Rivaroxaban limits complement activation compared with warfarin in antiphospholipid syndrome patients with venous thromboembolism.
Arachchillage, D R J; Mackie, I J; Efthymiou, M; Chitolie, A; Hunt, B J; Isenberg, D A; Khamashta, M; Machin, S J; Cohen, H.
Afiliação
  • Arachchillage DR; Department of Haematology, Haemostasis Research Unit, University College London, London, UK.
  • Mackie IJ; Department of Haematology, Haemostasis Research Unit, University College London, London, UK.
  • Efthymiou M; Department of Haematology, Haemostasis Research Unit, University College London, London, UK.
  • Chitolie A; Department of Haematology, Haemostasis Research Unit, University College London, London, UK.
  • Hunt BJ; Thrombosis and Haemophilia, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Isenberg DA; Department of Haematology, Kings College London, London, UK.
  • Khamashta M; Centre for Rheumatology, Division of Medicine, University College London, London, UK.
  • Machin SJ; Lupus Research Unit, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Cohen H; Department of Rheumatology, Kings College London, London, UK.
J Thromb Haemost ; 14(11): 2177-2186, 2016 11.
Article em En | MEDLINE | ID: mdl-27541499

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Varfarina / Coagulação Sanguínea / Síndrome Antifosfolipídica / Tromboembolia Venosa / Inibidores do Fator Xa / Rivaroxabana / Anticoagulantes Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Varfarina / Coagulação Sanguínea / Síndrome Antifosfolipídica / Tromboembolia Venosa / Inibidores do Fator Xa / Rivaroxabana / Anticoagulantes Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article